摘要
目的:观察丹红注射液治疗脑梗死的临床疗效。方法:治疗组30例,用丹红注射液治疗;对照组26例,用川芎嗪注射液治疗。观察并比较2组患者神经功能缺损评分、临床疗效及用药期间的不良反应。结果:丹红注射液治疗组总有效率为86.67%,对照组总有效率为65.38%,2组比较差异有统计学意义(P<0.05)。结论:丹红注射液治疗脑梗死有效、安全,且疗效优于川芎嗪注射液。
OBJECTIVE： To observe the curative effect of Danhong injection in treating cerebral infarction. METHODS： 30 patients （trial group） were assigned to receive Danhong injection, while 26 （control group） to receive Ligustrazine injection. The neurologic impairment score, clinical efficacy and ADRs during medication were compared between the two groups. RESULTS- The total effective rates in trial group vs. in control group were 86.67% vs. 65.38%, showing significant differences between the two groups（P 〈 0.05）,CONCLUSION： Danhong injection was proved to be safe and effective in treating cerebral infarction, and it is superior to Ligustrazine injection in curative efficacy.
出处
《中国药房》
CAS
CSCD
北大核心
2007年第24期1889-1890,共2页
China Pharmacy
关键词
丹红注射液
脑梗死
临床疗效
川芎嗪注射液
Danhong injection
Cerebral infarction
Curative efficacy
Ligustrazine injection
